Purchases and Sales Made in Q1 2025 in Krystal Biotech, Inc. (KRYS)
This table provides information about the institutional ownership of Krystal Biotech, Inc. (KRYS) during Q1 2025. The information is specifically focused on institutions that hold shares of Krystal Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-51.1K- 33.63% |
$7.28M - $9.93M
|
101K
$15.1M
|
|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-52.3K- 4.09% |
$7.46M - $10.2M
|
1.23M
$184M
|
|
|
May 14, 2025
Q1 2025
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-53K- 46.68% |
$7.56M - $10.3M
|
60.5K
$9.09M
|
|
|
May 09, 2025
Q1 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-53.2K- 1.85% |
$7.58M - $10.3M
|
2.83M
$424M
|
|
|
May 13, 2025
Q1 2025
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-54.7K- 9.29% |
$7.8M - $10.6M
|
534K
$80.2M
|
|
|
May 13, 2025
Q1 2025
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-64.4K- 29.87% |
$9.19M - $12.5M
|
151K
$22.7M
|
|
|
May 14, 2025
Q1 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-98.6K- 19.35% |
$14.1M - $19.2M
|
411K
$61.7M
|
|
|
May 15, 2025
Q1 2025
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-100K- 12.68% |
$14.3M - $19.4M
|
688K
$103M
|
|
|
Apr 14, 2025
Q1 2025
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-121K- 99.45% |
$17.2M - $23.5M
|
673
$101K
|
|
|
May 13, 2025
Q1 2025
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-165K- 89.67% |
$23.5M - $32.1M
|
19K
$2.85M
|
|
|
May 02, 2025
Q1 2025
|
Jennison Associates LLC
|
SELL
|
- |
-270K- 88.93% |
$38.5M - $52.5M
|
33.6K
$5.04M
|